- Home
- ENLV vs BYRN Comparison
ENLV vs BYRN Comparison
Compare ENLV & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENLV | BYRN |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 136.3M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ENLV | BYRN |
|---|---|---|
| Price | $1.52 | $3.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $20.00 | ★ $23.17 |
| AVG Volume (30 Days) | 289.4K | ★ 825.6K |
| Earning Date | 05-29-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,566,295.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | N/A | $16.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1692.08 |
| 52 Week Low | $0.43 | $3.17 |
| 52 Week High | $7.64 | $30.62 |
Technical Indicators
Market Signals| Indicator | ENLV | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 40.85 |
| Support Level | $0.70 | $3.17 |
| Resistance Level | $1.81 | $5.17 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 4.73 | 6.39 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.